Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis leads a $28M round for rare disease biotech Merganser
Novartis leads a $28M round for rare disease biotech Merganser
Novartis leads a $28M round for rare disease biotech Merganser
Submitted by
admin
on February 19, 2015 - 9:59am
Source:
Fierce Biotech
News Tags:
Novartis
Novartis Venture Fund
Merganser Biotech
Headline:
Novartis leads a $28M round for rare disease biotech Merganser
Do Not Allow Advertisers to Use My Personal information
